43 related articles for article (PubMed ID: 28583001)
1. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer.
Qiao H; Zhu Z; Fang D; Sun Y; Kang C; Di L; Zhang L; Gao Y
J Drug Target; 2018 Jan; 26(1):75-85. PubMed ID: 28583001
[TBL] [Abstract][Full Text] [Related]
2. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.
Dong Y; Liao H; Yu J; Fu H; Zhao D; Gong K; Wang Q; Duan Y
J Nanobiotechnology; 2019 Dec; 17(1):125. PubMed ID: 31870362
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer.
Itoo AM; Paul M; Ghosh B; Biswas S
Carbohydr Polym; 2022 Apr; 282():119108. PubMed ID: 35123744
[TBL] [Abstract][Full Text] [Related]
5. Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety.
Zhang B; Li L; Huang M; Zhao E; Li Y; Sun J; He Z; Fu C; Liu G; Sun B
Nano Lett; 2024 Mar; 24(12):3759-3767. PubMed ID: 38478977
[TBL] [Abstract][Full Text] [Related]
6. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Amiri-Kordestani L; Basseville A; Kurdziel K; Fojo AT; Bates SE
Drug Resist Updat; 2012; 15(1-2):50-61. PubMed ID: 22464282
[TBL] [Abstract][Full Text] [Related]
7. Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.
Mei KC; Liao YP; Jiang J; Chiang M; Khazaieli M; Liu X; Wang X; Liu Q; Chang CH; Zhang X; Li J; Ji Y; Melano B; Telesca D; Xia T; Meng H; Nel AE
ACS Nano; 2020 Oct; 14(10):13343-13366. PubMed ID: 32940463
[TBL] [Abstract][Full Text] [Related]
8. Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer.
Cheng J; Li J; Yu Q; Li P; Huang J; Li J; Guan L; Xu Z; Xiao J; Duan X
J Nanobiotechnology; 2024 May; 22(1):297. PubMed ID: 38812019
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol sulfate-mediated ion-pairing facilitates the self-nanoassembly of hydrophilic cationic mitoxantrone.
Zhang J; Fang H; Dai Y; Li Y; Li L; Zuo S; Liu T; Sun Y; Shi X; He Z; Sun J; Sun B
J Colloid Interface Sci; 2024 Sep; 669():731-739. PubMed ID: 38735255
[TBL] [Abstract][Full Text] [Related]
10. Self-Supplied Reactive Oxygen Species-Responsive Mitoxantrone Polyprodrug for Chemosensitization-Enhanced Chemotherapy under Moderate Hyperthermia.
Zhang H; Wang J; Wu R; Zheng B; Sang Y; Wang B; Song L; Hu Y; Ma X
Adv Healthc Mater; 2024 May; 13(12):e2303631. PubMed ID: 38278138
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-triggered prodrugs: Design strategies, potential applications, and perspectives.
Zhao J; Li X; Ma T; Chang B; Zhang B; Fang J
Med Res Rev; 2024 May; 44(3):1013-1054. PubMed ID: 38140851
[TBL] [Abstract][Full Text] [Related]
12. Dynamic and Assembly Characteristics of Deep-Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems.
Pavlović RZ; Finnegan TJ; Metlushko A; Hansen AL; Waudby CA; Wang X; Hoefer N; McComb DW; Pavić A; Plackić N; Novaković J; Bradić J; Jeremić N; Jakovljević V; Šmit B; Matić S; Alvarez-Saavedra MA; Čapo I; Moore CE; Stupp SI; Badjić JD
Chemistry; 2023 Dec; 29(68):e202303374. PubMed ID: 37851342
[TBL] [Abstract][Full Text] [Related]
13. A reduction-responsive drug delivery with improved stability: disulfide crosslinked micelles of small amiphiphilic molecules.
Li M; Ling L; Xia Q; Li X
RSC Adv; 2021 Mar; 11(21):12757-12770. PubMed ID: 35423790
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal "Tri-Therapy".
Gou S; Monod M; Salomon D; Kalia YN
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214004
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive micelles self-assembled from star-shaped TPGS copolymers with ortho ester linkages for enhanced MDR reversal and chemotherapy.
Xu Y; Wang S; Yang L; Dong Y; Zhang Y; Yan G; Tang R
Asian J Pharm Sci; 2021 May; 16(3):363-373. PubMed ID: 34276824
[TBL] [Abstract][Full Text] [Related]
16. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment.
Guan Y; Wang LY; Wang B; Ding MH; Bao YL; Tan SW
Curr Med Sci; 2020 Apr; 40(2):218-231. PubMed ID: 32337683
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease.
Yu J; Peng J; Luan Z; Zheng F; Su W
Molecules; 2019 Jan; 24(2):. PubMed ID: 30634538
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.
Tan S; Zou C; Zhang W; Yin M; Gao X; Tang Q
Drug Deliv; 2017 Nov; 24(1):1831-1842. PubMed ID: 29182031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
